51 – 100 of 123
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Is Breast-conserving Therapy Really a Good Option for BRCA1/2 Mutation Carriers?
(
- Contribution to journal › Article
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
- 2015
-
Mark
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.
(
- Contribution to journal › Article
-
Mark
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
(
- Contribution to journal › Article
-
Mark
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.
(
- Contribution to journal › Article
-
Mark
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
(
- Contribution to journal › Article
-
Mark
Clinical Management of Prostate Cancer in Men with BRCA Mutations.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical and molecular complexity of breast cancer metastases.
(
- Contribution to journal › Scientific review
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer
(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
(
- Contribution to journal › Article
-
Mark
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.
(
- Contribution to journal › Article
-
Mark
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
(
- Contribution to journal › Article
-
Mark
Svenskt samarbete för genomiska analyser av bröstcancervävnad. Grund för framtidens individualiserade cancerbehandling
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2013
-
Mark
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
(
- Contribution to journal › Article
-
Mark
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
(
- Contribution to journal › Article
-
Mark
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
(
- Contribution to journal › Article
- 2012
-
Mark
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
(
- Contribution to journal › Article
-
Mark
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
(
- Contribution to journal › Article
-
Mark
Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
(
- Contribution to journal › Article
-
Mark
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(4). p.645-657(
- Contribution to journal › Article
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
-
Mark
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
(
- Contribution to journal › Article
-
Mark
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
(
- Contribution to journal › Article
-
Mark
Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
-
Mark
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
(
- Contribution to journal › Article
-
Mark
Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer.
(
- Contribution to journal › Article
-
Mark
Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey.
(
- Contribution to journal › Article
- 2010
-
Mark
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
(
- Contribution to journal › Article
-
Mark
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
(
- Contribution to journal › Article
-
Mark
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
(
- Contribution to journal › Article
-
Mark
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
(
- Contribution to journal › Article
-
Mark
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
-
Mark
Improving Surveillance and Quality of Life of BRCA Mutation Carriers.
(
- Contribution to journal › Article
- 2008
-
Mark
Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
(
- Contribution to journal › Article
-
Mark
Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families
(
- Contribution to journal › Article
-
Mark
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
(
- Contribution to journal › Debate/Note/Editorial
- 2005
-
Mark
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
(
- Contribution to journal › Article
-
Mark
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
(
- Contribution to journal › Article
- 2004
-
Mark
BRCA1 och BRCA2 har nått kliniken. Tioårigt fynd av genmutation ger nu möjlighet förebygga ärftlig bröstcan
(
- Contribution to journal › Article
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article